🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma › Nebraska

Qorannoo klinikaalii Lymphoma Nebraska keessatti

Qorannoo 7 Lymphoma f Nebraska keessatti hirmaatuu jiru.

Magaalota Nebraska keessatti

Takkalaa qorannoo (Ingiliffa)

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • University of Nebraska Medical Center, Omaha
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

  • University of Nebraska Medical Center, Omaha
Namoota walitti qabaa jira
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT04898790

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

  • University of Nebraska Medical Center, Omaha
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06528301

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • University of Nebraska Medical Center (UNMC), Omaha
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07188558

Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy

  • Unversity of Nebraska Medical Center, Omaha
Namoota walitti qabaa jira
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05135351

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Fred and Pamela Buffett Cancer Center, Omaha
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT03328078

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 95 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT04329728

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.